Epilepsy Trial, Recruiting NCT05632978 Sponsor: Cardiff and Vale University Health Board Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05632978
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • People who are being investigated for epilepsy and are receiving clinical care through the epilepsy unit at Cardiff & Vale University Health Board, or through regional clinics in Cwm Taf.
  • People who are at least 16 years old.
  • People who are willing and able to give their informed consent to take part.

Who may not be able to join:

  • There are no listed exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Khalid Hamandi, Cardiff & Vale University Health Board

Phone: +44(0)2921843454

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cardiff and Vale University Health Board
Registry
ClinicalTrials.gov
Start date
24 April 2023
Est. completion
1 December 2032

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Establish population-based cohort of people with epilepsy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov